Holen Sie sich die Stockscreener-App
1.54
0.00%
0.00
Vorhandelsmarkt:
1.54
Schlusskurs vom Vortag:
$1.54
Offen:
$1.55
24-Stunden-Volumen:
1.60M
Relative Volume:
0.71
Marktkapitalisierung:
$107.17M
Einnahmen:
$151.64M
Nettoeinkommen (Verlust:
$-37.23M
KGV:
-3.9346
EPS:
-0.3914
Netto-Cashflow:
$-21.18M
1W Leistung:
+28.33%
1M Leistung:
-9.41%
6M Leistung:
+3.36%
1J Leistung:
-61.01%
1-Tages-Spanne:
$1.46
$1.59
1-Wochen-Bereich:
$1.18
$1.59
52-Wochen-Spanne:
$0.80
$4.8495
Neuronetics Inc Stock (STIM) Company Profile
Firmenname
Neuronetics Inc
Sektor
Branche
Telefon
877-600-7555
Adresse
3222 PHOENIXVILLE PIKE, MALVERN, PA
Compare STIM vs ABT, SYK, MDT, BSX, EW
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
STIM
Neuronetics Inc
|
1.54 | 107.17M | 151.64M | -37.23M | -21.18M | -0.3914 |
ABT
Abbott Laboratories
|
85.60 | 150.32B | 45.13B | 6.28B | 7.38B | 3.5895 |
SYK
Stryker Corp
|
305.09 | 117.93B | 25.27B | 3.34B | 4.57B | 8.6334 |
MDT
Medtronic Plc
|
73.81 | 97.02B | 35.48B | 4.64B | 5.41B | 3.582 |
BSX
Boston Scientific Corp
|
48.31 | 72.99B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
86.47 | 49.50B | 6.30B | 1.07B | 1.09B | 1.8406 |
Neuronetics Inc Stock (STIM) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-08-13 | Herabstufung | William Blair | Outperform → Mkt Perform |
| 2021-10-13 | Herabstufung | BTIG Research | Buy → Neutral |
| 2021-10-13 | Herabstufung | William Blair | Outperform → Mkt Perform |
| 2021-01-22 | Hochstufung | William Blair | Mkt Perform → Outperform |
| 2020-02-06 | Eingeleitet | BTIG Research | Buy |
| 2018-07-24 | Eingeleitet | Canaccord Genuity | Buy |
Alle ansehen
Neuronetics Inc Aktie (STIM) Neueste Nachrichten
Neuronetics, Inc. (STIM) Submits Form 8-K Reporting Shareholder Vote Results – Key Filing Details and Company Information - Minichart
What Does Jorey Chernett's Recent Buying Spree Signal for Neuronetics (STIM) - Kavout
Neuronetics (STIM) director Megan Rosengarten granted 30,000 RSUs, now holds 170,890 shares - Stock Titan
Director at Neuronetics (STIM) receives 30,000-share RSU grant - Stock Titan
Neuronetics (STIM) director awarded 30,000 RSUs vesting by 2027 - Stock Titan
Neuronetics (STIM) director Sheryl Conley awarded 30,000 RSUs in stock grant - Stock Titan
Neuronetics (STIM) director granted 36,250 RSUs, holdings rise to 625,017 shares - Stock Titan
Neuronetics (STIM) director Avinash Amin receives 30,000 RSU equity award - Stock Titan
Neuronetics (STIM) shareholders back directors, auditor and 2026 equity plan - Stock Titan
Neuronetics Inc stock (US63009R1005): Nasdaq shares steady as investors look beyond Q1 update - AD HOC NEWS
Neuronetics Inc stock (US63009R1005): shares little changed as investors weigh Q1 2026 update - AD HOC NEWS
PRISM MarketView Spotlights Seven Public Companies Advancing Mental Health Innovation During National Mental Health Awareness Month - StreetInsider
Large Neuronetics (STIM) holder discloses 15.17% stake and sole control - Stock Titan
STIMNeuronetics Inc Stock Price and Quote - Finviz
Neuronetics (STIM) Q1 2026 Earnings Transcript - AOL.com
Neuronetics Analyst Ratings and Price Targets | NASDAQ:STIM - Benzinga
Neuronetics Inc (STIM) Stock Price, Quote, News & History - Benzinga
Neuronetics, Inc. Signs $26,000/Month Consulting Agreement with Francis X. Brown III – 8-K Filing Details and Agreement Terms - Minichart
Neuronetics updates consulting agreement for interim financial officer By Investing.com - Investing.com South Africa
Neuronetics updates consulting agreement for interim financial officer - Investing.com
Neuronetics (NASDAQ: STIM) sets new monthly pay for interim finance chief - Stock Titan
Neuronetics, Inc. Appoints Francis X. Brown III as Accounting Officer, Effective as of May 5, 2026 - marketscreener.com
Neuronetics (STIM) ex-CFO corrects insider sale to 8,569 tax-withheld shares - Stock Titan
STIM PE Ratio & Valuation, Is STIM Overvalued - Intellectia AI
STIM SEC FilingsNeuronetics 10-K, 10-Q, 8-K Forms - Stock Titan
Insider Buying: Jorey Chernett Acquires 100,000 Shares of Neuron - GuruFocus
Neuronetics 10% owner Chernett buys $117,000 in common stock By Investing.com - Investing.com South Africa
Neuronetics 10% owner Chernett buys $117,000 in common stock - Investing.com UK
Neuronetics (NASDAQ: STIM) large holder buys 100,000 shares - Stock Titan
Neuronetics(STIM) Stock Options Chain | Quotes & News - Moomoo
Neuronetics stock (US63009R1005): earnings move puts focus back on growth outlook - AD HOC NEWS
Neuronetics Revenue Rises as Clinic Business Expands - MyChesCo
Neuronetics partners with ANT Neuro on neuronavigation tech By Investing.com - Investing.com South Africa
Neuronetics and Ant Neuro announce strategic collaboration to integrate neuronavigation with Neurostar TMS treatment - marketscreener.com
Neuronetics partners with ANT Neuro on neuronavigation tech - Investing.com India
Neuronetics And Ant Neuro Announce Strategic Collaboration To Integrate Neuronavigation With Neurostar Tms Treatment - TradingView
Neuronetics and ANT Neuro Announce Strategic Collaboration to Integrate Neuronavigation with NeuroStar TMS Treatment - The Manila Times
Neuronetics (STIM) interim PAO reports 19,968 Common Stock shares - Stock Titan
Insider Buying: Jorey Chernett Acquires 475,000 Shares of Neuron - GuruFocus
Neuronetics: Jorey Chernett buys $636,500 in shares By Investing.com - Investing.com India
Neuronetics: Jorey Chernett buys $636,500 in shares - Investing.com UK
Neuronetics Insider Bought Shares Worth $636,500, According to a Recent SEC Filing - marketscreener.com
Neuronetics 10% Owner Purchased Shares Worth Over $636K - TradingView
Neuronetics | 4: Statement of changes in beneficial ownership of securities-10% Owner Chernett Jorey - Moomoo
Large Neuronetics (STIM) shareholder adds 475,000 shares in open-market buy - Stock Titan
Neuronetics stock (US63009R1005): Innovative Neurostimulation Leader - AD HOC NEWS
MSN Money - MSN
Neuronetics outlines $160M-$166M 2026 revenue outlook with focus on $2.5M-$3M annualized cost savings - MSN
Finanzdaten der Neuronetics Inc-Aktie (STIM)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.59%
1.94%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):